Produced by W2D1 Media. Work with us →

Brandon Capital

Brandon Capital is Australasia's leading life-sciences venture capital firm, based in Melbourne and founded in 2006 by Chris Nave. It invests in early-stage biomedical and pharmaceutical companies through its BioCatalyst funds, the sixth of which closed at over A$439 million in July 2025.

brandoncapital.vc ↗ Hear the team
Sector
Venture capital (life sciences)
Business model
Venture fund (life sciences)
Headquarters
Melbourne
Offices
Melbourne, Sydney, London
Markets
Australia, New Zealand, US, UK

Sources: brandoncapital.vc, brandoncapital.vc

2people interviewed
2episodes across 2 shows

The team on Day One

Katharine Giles Venture Partner, Brandon Capital; CEO, OncoRes Medical 1 episode → Prashanth Rajan Associate, Brandon Capital 1 episode →

Hear from the team

▶
28 August 2026 · Investment Thesis Katharine Giles of Brandon Capital - The Investment Thesis Behind Backing Life Sciences Katharine Giles
▶
26 July 2026 · What The Health The A$2.2B Myricx Bio Deal, AI's Healthcare Land Grab and Preventive Health Prashanth Rajan

Spot something wrong? Suggest a correction Updated 25 September 2026

—